Engram Reactivation and Depression - Annissa DeSilva
In
Ramirez et al. 2015, the optogenetic reactivation of a positive memory engram
in the dentate gyrus (DG) was sufficient to increase struggling behavior in the
tail suspension test (TST), increase the consumption of sucrose in the sucrose preference
test (SPT), and decreased latency in the novelty suppressed feeding test (NSFT).
What I found most interesting about this paper was that the acute reactivation
of the DG engram only relived symptoms temporarily, however chronic
reactivation of the neurons over 5 days showed reversal of stress induced
symptoms. Additionally, histological analysis revealed that mice under all
stressed conditions, except for the 5-day chronic activation group and control
had decreased neurogenesis, in fact the 5-day chronic and the control group
actually had increased neurogenesis. I think that the researchers included this
data point to assert that this positive memory activation could serve as a potential
treatment method for depression, especially emphasizing the fact that neurogenesis
was seen after 5 days versus 2 weeks as observed in anti-depressant treatment. As
discussed previously, neurogenesis in the hippocampus may not be the cause of
the anti-depressant efficacy however anti-depressant action may promote brain-derived
neurotrophic factor (BDNF), a neurotropic factor that stimulates neurogenesis
and may provide a therapeutic effect through long term potentiation (LTP). This
is relevant to the current study because BDNF is implicated in the formation of
context learning and memory. Studies have found increased BDNF levels in
hippocampi of mice after learning tasks such as the Morris water maze (Kesslak,
So, Choi, Cotman, & Gomez-Pinilla, 1998). BDNF is also theorized to be an
essential factor for synaptic plasticity related to long term memory storage (Lee,
2004). The authors suggest that their research opens the possibility of further
research relating the two, perhaps the activation of the positive engram
stimulates BDNF transcription or is up-regulated in some way to potentially
contribute to the alleviation of depressive symptoms seen with anti-depressants.
It has been theorized that those with depression display decreased positive memory
learning potentially due to lack of LTP in the hippocampus (Dillon, 2015) which
could contribute to anhedonia. In the future it would be interesting to compare
the effectiveness of chronic DG engram reactivation and chronic anti-depressant
use in multiple behavioral assays to truly evaluate this method use as a
potential treatment and its specific effect.
The
pairing of the two papers were very interesting regarding future clinical treatment
of depression. After reading both papers, it seemed as if the natural
progression of the research was to investigate if positive false memories can
be made, and if so, can we alter a true negative memory with the false positive
memory leading to a reversal of stress induced depressive behavior? The idea of
changing the emotionality of a memory is reminiscent of cognitive behavioral
therapy (CBT) where the aim is to alter negative thoughts into positive ones
however, the researchers suggest that this engram activation is more salient
than external positive stimuli, if true the effect of engram activation may result
in a more “efficient” therapy.
Citations:
Dillon, D. G. (2015). The neuroscience of positive memory
deficits in depression. Frontiers in Psychology,6.
doi:10.3389/fpsyg.2015.01295
Kesslak, J. P., So, V., Choi, J., Cotman, C. W., &
Gomez-Pinilla, F. (1998). Learning upregulates brain-derived neurotrophic
factor messenger ribonucleic acid: A mechanism to facilitate encoding and
circuit maintenance? Behavioral Neuroscience,112(4), 1012-1019.
doi:10.1037/0735-7044.112.4.1012
Lee, J. L. (2004). Independent Cellular Processes for
Hippocampal Memory Consolidation and Reconsolidation. Science,304(5672),
839-843. doi:10.1126/science.1095760
Comments
Post a Comment